Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UKCCSG Stage IIB/3 Neuroblastoma Pilot Study
NCT00416676Phase 3Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of vincristine, cyclophosphamide, cisplatin, etoposide and carboplatin in neuroblastoma, sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
02
Drugs
vincristinecyclophosphamidecisplatinetoposidecarboplatin
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00416676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00416676.